Does elevated free T4 with low free T3 and higher TSH reflect impaired T4-to-T3 conversion?

A thyroid panel showing elevated or high-normal free T4 (FT4) paired with low free T3 (FT3) and elevated thyroid-stimulating hormone (TSH) represents a highly discordant biochemical state that deviates from typical physiological feedback loops.

Clinical evidence and axis strain

• HPT axis discordance: Under normal physiological feedback, elevated circulating FT4 levels should suppress pituitary TSH secretion. The co-occurrence of elevated TSH with high FT4 indicates hypothalamic-pituitary-thyroid (HPT) axis strain, where the pituitary continually drives TSH output to compensate for insufficient tissue levels of active T3.
• Therapeutic implications: This pattern is frequently observed in hypothyroid or athyreotic patients receiving levothyroxine (LT4) monotherapy. Exogenous LT4 can elevate FT4 levels without successfully normalizing FT3, resulting in a low FT3/FT4 ratio due to limited peripheral conversion efficiency.

Mechanistic pathways of conversion impairment

• Deiodinase enzyme down-regulation: Approximately 80% of circulating active T3 is derived from the peripheral conversion of T4. This process relies on outer-ring deiodination mediated by deiodinase 1 (DIO1) and deiodinase 2 (DIO2) enzymes.
• Impaired DIO2 expression: Reduced expression or activity of the DIO2 enzyme directly impairs the peripheral conversion of T4 to T3. This enzymatic blockade can be triggered by systemic stressors, severe chronic illness (non-thyroidal illness syndrome), nutritional deficits, or genetic factors, leaving the abundant FT4 prohormone unconverted.

Bottom line

• Bottom line: A laboratory pattern of elevated FT4, low FT3, and higher TSH is a clear biochemical signal of impaired peripheral T4-to-T3 conversion and HPT axis strain. It demonstrates that despite abundant circulating prohormone, localized conversion barriers prevent the generation of active thyroid hormone, prompting a compensatory rise in TSH.